scholarly article | Q13442814 |
P50 | author | Peter Skewes-Cox | Q38155159 |
Pavel A Nikitin | Q62926684 | ||
Andrea Carfì | Q88702827 | ||
P2093 | author name string | David T Barkan | |
Brigitte Wiedmann | |||
Weidong Zhong | |||
Adam Feire | |||
Claudio Ciferri | |||
James J Lin | |||
Hetalkumar D Patel | |||
Nadine Jarousse | |||
Christy M Hebner | |||
Tahmineh Akbarnejad Yazdi | |||
Thomas Gesner | |||
P2860 | cites work | Vaccine prevention of maternal cytomegalovirus infection | Q24645631 |
A neutralizing anti-gH/gL monoclonal antibody is protective in the guinea pig model of congenital CMV infection | Q27329077 | ||
Isolation of human monoclonal antibodies that potently neutralize human cytomegalovirus infection by targeting different epitopes on the gH/gL/UL128-131A complex | Q33558361 | ||
HCMV spread and cell tropism are determined by distinct virus populations | Q33798083 | ||
High-content screening to distinguish between attachment and post-attachment steps of human cytomegalovirus entry into fibroblasts and epithelial cells | Q33806689 | ||
Human cytomegalovirus virion protein complex required for epithelial and endothelial cell tropism | Q34212879 | ||
Structural basis for the recognition of human cytomegalovirus glycoprotein B by a neutralizing human antibody | Q34317887 | ||
A randomized trial of hyperimmune globulin to prevent congenital cytomegalovirus. | Q34413309 | ||
Human Cytomegalovirus gH/gL/gO Promotes the Fusion Step of Entry into All Cell Types, whereas gH/gL/UL128-131 Broadens Virus Tropism through a Distinct Mechanism | Q35913890 | ||
Structure of HCMV glycoprotein B in the postfusion conformation bound to a neutralizing human antibody. | Q36084954 | ||
Antibodies against the gH/gL/UL128/UL130/UL131 complex comprise the majority of the anti-cytomegalovirus (anti-CMV) neutralizing antibody response in CMV hyperimmune globulin | Q36155456 | ||
Preliminary evaluation of the safety and efficacy of standard intravenous immunoglobulins in pregnant women with primary cytomegalovirus infection | Q36505218 | ||
Cytomegalovirus vaccines fail to induce epithelial entry neutralizing antibodies comparable to natural infection | Q36973592 | ||
Human cytomegalovirus glycoproteins gB and gH/gL mediate epithelial cell-cell fusion when expressed either in cis or in trans | Q36974741 | ||
Cytomegalovirus cell tropism. | Q37219958 | ||
Immunocompromised hosts: perspectives in the treatment and prophylaxis of cytomegalovirus disease in solid-organ transplant recipients | Q37225866 | ||
How we treat cytomegalovirus in hematopoietic cell transplant recipients | Q37237427 | ||
An Attenuated CMV Vaccine with a Deletion in Tegument Protein GP83 (pp65 Homolog) Protects against Placental Infection and Improves Pregnancy Outcome in a Guinea Pig Challenge Model | Q37508272 | ||
How to trigger a killer: modulation of natural killer cell reactivity on many levels | Q38245101 | ||
Quantitative analysis of neutralizing antibody response to human cytomegalovirus in natural infection. | Q39468421 | ||
Human cytomegalovirus escapes a naturally occurring neutralizing antibody by incorporating it into assembling virions | Q39472513 | ||
Identification and expression of human cytomegalovirus transcription units coding for two distinct Fcgamma receptor homologs | Q39686594 | ||
Human cytomegalovirus UL131-128 genes are indispensable for virus growth in endothelial cells and virus transfer to leukocytes | Q39960937 | ||
Human monoclonal anti-cytomegalovirus (CMV) antibody (MSL 109): enhancement of in vitro foscarnet- and ganciclovir-induced inhibition of CMV replication | Q42282199 | ||
Neutralizing antibodies are unable to inhibit direct viral cell-to-cell spread of human cytomegalovirus | Q42284197 | ||
Antibodies to Recombinant-Derived Glycoprotein B after Natural Human Cytomegalovirus Infection Correlate with Neutralizing Activity | Q43517822 | ||
Randomized, placebo-controlled, double-blind study of a cytomegalovirus-specific monoclonal antibody (MSL-109) for prevention of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation | Q43682605 | ||
Human cytomegalovirus serum neutralizing antibodies block virus infection of endothelial/epithelial cells, but not fibroblasts, early during primary infection. | Q45396472 | ||
Molecular epidemiology of envelope glycoprotein H of human cytomegalovirus | Q48160552 | ||
Analysis of Interstrain Variation in Cytomegalovirus Glycoprotein B Sequences Encoding Neutralization-Related Epitopes | Q48224220 | ||
Passive Immunization during Pregnancy for Congenital Cytomegalovirus Infection | Q55982678 | ||
Biological efficacy of a chimeric antibody to the epidermal growth factor receptor in a human tumor xenograft model | Q77555291 | ||
P433 | issue | 8 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Cytomegalovirus | Q6946 |
monoclonal antibody | Q422248 | ||
P1104 | number of pages | 11 | |
P304 | page(s) | 4961-4971 | |
P577 | publication date | 2016-07-22 | |
P1433 | published in | Antimicrobial Agents and Chemotherapy | Q578004 |
P1476 | title | In Vitro Characterization of Human Cytomegalovirus-Targeting Therapeutic Monoclonal Antibodies LJP538 and LJP539 | |
P478 | volume | 60 |
Q60960338 | A Native Human Monoclonal Antibody Targeting HCMV gB (AD-2 Site I) |
Q90062923 | Advances in the Development of Therapeutics for Cytomegalovirus Infections |
Q47143843 | Antibody therapies for the prevention and treatment of viral infections. |
Q89517194 | Phase 2 Study of Anti-Human Cytomegalovirus Monoclonal Antibodies for Prophylaxis in Hematopoietic Cell Transplantation |
Q38926265 | Prospects of a vaccine for the prevention of congenital cytomegalovirus disease |
Q59812989 | Signatures of T and B Cell Development, Functional Responses and PD-1 Upregulation After HCMV Latent Infections and Reactivations in Nod.Rag.Gamma Mice Humanized With Cord Blood CD34 Cells |
Q92511027 | The N Terminus of Human Cytomegalovirus Glycoprotein O Is Important for Binding to the Cellular Receptor PDGFRα |
Q38764543 | Use of broadly neutralizing antibodies for HIV-1 prevention |
Search more.